James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 5,190 shares at $28.02 ($145K) on 2019-02-05, disclosed to the SEC on 2019-02-07.
Open-market sale of $145k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.02 | 2,595 | $73K | 50.0% |
| 2 | $28.02 | 2,595 | $73K | 50.0% |
| Total | $28.02 avg | 5,190 | $145K | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |